The prognostic value of cardiac MR was a prominent theme last week at the Society for Cardiovascular Magnetic Resonance meeting in San Francisco. Dr. Rishi Kaushal, a CMR researcher at the University of California, Los Angeles, presented results demonstrating that myocardial infarction size measured with cine and delayed-enhancement MR can predict the risk of mortality posed by the injury.
The prognostic value of cardiac MR was a prominent theme last week at the Society for Cardiovascular Magnetic Resonance meeting in San Francisco. Dr. Rishi Kaushal, a CMR researcher at the University of California, Los Angeles, presented results demonstrating that myocardial infarction size measured with cine and delayed-enhancement MR can predict the risk of mortality posed by the injury.
The rationale for Kaushal's study was a paradox in criteria for selecting candidates for an implantable cardioverter defibrillator (ICD). Several studies indicate that patients thought to be at high risk of sudden cardiac death have a higher mortality rate than patients in lower risk groups.
Patients with an ejection fraction between 31% and 40% and unsustained ventricular or inducible tachycardia qualify for an ICD. No clear guidelines for implantation exist for patients with ejection fractions greater than 40%, however, and they account for most of the patients who die suddenly because of their condition, Kaushal said.
Kaushal and colleagues at UCLA and Cedars-Sinai Medical Center in Los Angeles expected that additional clinical criteria would clarify the situation. His study examined whether MI size measured with cine and delayed-enhancement MR gives clinicians an additional indicator regarding who should obtain an ICD.
Kaushal's investigation was based on a study of 100 patients with coronary artery disease. Their mean age was 66 years, and 87% of the group was male. About six of 10 subjects had a previous MI, 23% had diabetes, and 49% were hypertensive. For the study, they were initially imaged with cine and delayed-enhancement MR as part of a routine cardiac examination. The mean left ventricular ejection fraction among the group was 34%.
Kaushal also measured the location and size of the previous MI. Regional wall thickening and contrast enhancement were measured using a 17-segment anatomic model. Viable segments exhibited less than 25% delayed enhancement.
Outcome data collected an average of 25 months later found that 15 subjects had died from cardiac events and another 26 had undergone myocardial revascularization or hospitalization to treat unstable angina or congestive heart failure. DE-MRI found myocardial damage suggesting a previous MI in nine of 10 patients.
Using Cox multivariant analysis, Kaushal determined that an infarction of greater than 15% of left ventricular mass and diminished ejection fraction were the only statistically significant predictors of death. The results led him to conclude that the extent of MI can predict if a patient is susceptible to a death that could be avoided with ICD implantation.
For more information from the Diagnostic Imaging archives:
Multisequence stress CMR shows promise
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.